Atgam (Pharmacia and Upjohn Company LLC)
Welcome to the PulseAid listing for the Atgam drug offered from Pharmacia and Upjohn Company LLC. This Immunoglobulin G [EPC],Lymphocyte Function Alteration [PE],Increased T Lymphocyte Destruction [PE],Antibody-Surface Protein Interactions [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Pharmacia and Upjohn Company LLC |
| NON-PROPRIETARY NAME: | EQUINE THYMOCYTE IMMUNE GLOBULIN |
| SUBSTANCE NAME: | EQUINE THYMOCYTE IMMUNE GLOBULIN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Immunoglobulin G [EPC],Lymphocyte Function Alteration [PE],Increased T Lymphocyte Destruction [PE],Antibody-Surface Protein Interactions [MoA],Immunoglobulins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1981-11-17 |
| END MARKETING DATE: | 0000-00-00 |
Atgam PLASMA DERIVATIVE Details:
| Item Description | Atgam from Pharmacia and Upjohn Company LLC |
| LABELER NAME: | Pharmacia and Upjohn Company LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 1981-11-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0009-7224_a3d8c75d-5661-4919-b664-3e42f69eda00 |
| PRODUCT NDC: | 0009-7224 |
| APPLICATION NUMBER: | BLA103676 |
Other EQUINE THYMOCYTE IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:
